Bridging the translational gap: what can synaptopathies tell us about autism?
Multiple molecular pathways and cellular processes have been implicated in the neurobiology of autism and other neurodevelopmental conditions. There is a current focus on synaptic gene conditions, or synaptopathies, which refer to clinical conditions associated with rare genetic variants disrupting...
Main Authors: | Ciara J. Molloy, Jennifer Cooke, Nicholas J. F. Gatford, Alejandro Rivera-Olvera, Sahar Avazzadeh, Judith R. Homberg, Joanes Grandjean, Cathy Fernandes, Sanbing Shen, Eva Loth, Deepak P. Srivastava, Louise Gallagher |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnmol.2023.1191323/full |
Similar Items
-
The Synaptic Gene Study: Design and Methodology to Identify Neurocognitive Markers in Phelan-McDermid Syndrome and NRXN1 Deletions
by: Jennifer Cooke, et al.
Published: (2022-02-01) -
Dissecting the Heterogeneity of Autism: Focus on Phelan-McDermid Syndrome
by: C. Lamschtein, et al.
Published: (2022-06-01) -
Clinical and Genetic Aspects of Phelan–McDermid Syndrome: An Interdisciplinary Approach to Management
by: Francisco Cammarata-Scalisi, et al.
Published: (2022-03-01) -
Psychiatric illness and regression in individuals with Phelan-McDermid syndrome
by: Teresa M. Kohlenberg, et al.
Published: (2020-02-01) -
Phelan-McDermid syndrome: a classification system after 30 years of experience
by: Katy Phelan, et al.
Published: (2022-01-01)